Sygehus Lillebaelt Vejle Sygehus — Clinical Trial Site

41 Registered trials

11 Currently recruiting

Organisation

Sygehus Lillebaelt Vejle Sygehus

Location

Vejle, Denmark

Identifier

ORG-100031262

Address

Kabbeltoft 25, 7100, Denmark

Departments

4003:Onkologisk afdeling/KFE
Department of Anesthesiolgy
Department of Cardiology 76362000
Department of Hematology
Department of Medicine
Department of Medicine, Hematological Section
Department of Oncology
Department of Regional Health Research
Department of Respiratory Diseases
Dept. Of Hematology Section of Internal Medicine
Hematology
internal medicin
Lungemedicinsk Afdeling
Medical
Medical Department
N/A
Oncology
Onkologisk Afdeling
Onkologisk Afdelning
Orthopaedic Surgery

Clinical trials at this site (41)

Search interface

A seamless, phase 1b/2 multiple ascending dose/proof of concept study of XTMAB-16 in patients with pulmonary sarcoidosis with or without ext… Not authorised

2022-502877-41-00 Pulmonary sarcoidosis with or without extrapulmonary ma 9
A study to assess the efficacy and safety of OATD-01 for the treatment of active pulmonary sarcoidosis. Not authorised

2023-506642-23-00 Active Pulmonary Sarcoidosis 4
A Long-term Multicenter Open-label Study to Evaluate the Long-term Safety and Durability of Effect of XTMAB-16 in Patients With Pulmonary Sa… Pending

2023-507590-18-00 Pulmonary sarcoidosis with or without extrapulmonary ma 4
Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults with Non-cystic Fibrosis Bronchiectasis (NCFB) Pending

2024-518821-13-00 Non-cystic Fibrosis Bronchiectasis 4
Molecularly Tailored Therapy versus Standard Care in Advanced Pancreatic Cancer Pending

2025-522431-34-00 Advanced pancreatic cancer 4
Phase 4, double-blind study evaluating the response on computed tomography (CT) lung density decline rates of Respreeza / Zemaira weekly for… Pending

2025-522964-33-00 Alpha1-proteinase inhibitor deficiency 6
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer (TREVI-OC-01) Recruiting

2025-520466-22-00 Advanced Platinum-resistant Epithelial Ovarian Cancer 5 2026-04-29
A Study of Abemaciclib (LY2835219) with Abiraterone in Men with Prostate Cancer that has Spread to Other Parts of the Body and is Expected t… Recruiting

2022-500461-28-06 High-Risk Metastatic Hormone-Sensitive Prostate Cancer 5 2022-09-15
MOVE-IT Recruiting

2024-517123-39-00 crohns disease 6 2025-12-15
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutec… Recruiting

2024-518015-19-00 Colorectal Cancer 4 2025-09-24
A seamless, phase 1b/2 multiple ascending dose/proof of concept study of XTMAB-16 in patients with pulmonary sarcoidosis with or without ext… Recruiting

2022-502877-41-01 Pulmonary sarcoidosis with or without extrapulmonary ma 9 2025-02-10
C2321003: A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men with Metastatic Castration-Resistant… Recruiting

2024-511652-40-00 METASTATIC CASTRATION RESISTANT PROSTATE CANCER 5 2025-02-05
An open-label study to assess reduction of daily asthma medication with tezepelumab in patients 12 to 80 years of age with severe asthma Recruiting

2024-512113-41-00 Severe Asthma 5 2024-11-20
Self-administration of subcutaneous Elranatamab in the patients’ homes (ERICA) Recruiting

2023-507876-30-00 Multiple Myeloma 4 2024-09-04
A Phase 3 Randomized Study Comparing Teclistamab in Combination with Daratumumab SC and Lenalidomide (Tec-DR) and Talquetamab in Combination… Recruiting

2023-503442-30-00 Multiple Myeloma 5 2022-10-14
Phase 2 Study of Adagrasib Monotherapy and in Combination With Pembrolizumab and Phase 3 Study of Adagrasib in Combination with Pembrolizuma… Recruiting

2023-508922-83-00 Advanced Non-Small Cell Lung Cancer 10 2021-03-17
An early study to investigate a new medicine for Subjects with Relapsed or Refractory Non-Hodgkin Lymphomas (R/R NHL) Recruiting

2024-515690-10-00 Follicular B-cell non-Hodgkin's lymphoma 9 2019-05-10
Melatonin for prevention of agitation after surgery in children (MELA-PAED). Ended

2024-517592-20-00 Emergence delirium 5 2026-05-30
A study of BMS-986504 in combination with Nab-p/Gem versus placebo in combination with Nab-p/Gem in untreated metastatic PDAC with homozygou… Ended

2025-522598-12-00 Untreated Metastatic Pancreatic Ductal Adenocarcinoma 10 2025-12-17
TALTEC: A phase II study measuring MRD negativity after bispecific T-cell redirectors TALquetamab and TEClistamab consolidation as part of f… Ended

2023-508212-38-00 Multiple Myeloma 4 2024-06-11
Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change i… Ended

2023-506906-38-00 Follicular Lymphoma 5 2024-05-23
Subcutaneous immunoglobulin (HyQvia) against early infections in multiple myeloma: SHIELD Ended

2023-505053-40-00 Multiple Myeloma 4 2023-11-30
Phase II multicenter clinical trial: Mosunetuzumab for early relapse of follicular lymphoma in the Nordic countries (MERLIN/NLG-FL6/ML43841) Ended

2022-500100-21-01 Follicular lymphoma 4 2023-09-11
Safety of ibuprofen after major orthopaedic surgeries Ended

2022-502502-32-00 Hip and knee arthroplasties 11 2023-04-17